PTPRC and neoplasm: We sorted Macro CD5L+ (CD45+ F4/80+ FOLR2+) in the tumor environment of orthotopic injection model and injected the sorted Macro CD5L+ into the subcutaneous iCCA model to directly explore its effect on GOLP therapy.